‹ PCVX latest research

PCVX (Vaxcyte, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed PCVX on 3 market nights between April 29, 2026 and July 30, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

3 calls 3 BUY · 0 HOLD · 0 SELL BUY calls up after 20 trading days: 1 of 3
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
July 30, 2026 BUY $52.98 — / — +5.2% +9.3%
The current market regime and the stock's technicals do not support a buy.
April 30, 2026 BUY $57.32 $60.50 / $48.72 -10.1% -10.2%
The current market regime is neutral, and while fundamentals and sentiment are bullish, technicals are neutral, and the high risk score necessitates a clear catalyst for entry.
April 29, 2026 BUY $58.73 — / — -0.4% -10.9%
The stock is consolidating, and a clear catalyst is needed for a directional trade.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.